Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for PRTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 51.74M
March 31, 2026 53.08M
December 31, 2025 53.83M
September 30, 2025 53.83M
June 30, 2025 53.83M
March 31, 2025 53.83M
December 31, 2024 53.83M
September 30, 2024 53.81M
June 30, 2024 53.77M
March 31, 2024 53.72M
December 31, 2023 53.68M
September 30, 2023 53.64M
June 30, 2023 53.49M
March 31, 2023 52.68M
December 31, 2022 52.10M
September 30, 2022 47.89M
June 30, 2022 46.81M
March 31, 2022 46.75M
December 31, 2021 46.66M
September 30, 2021 46.53M
June 30, 2021 44.91M
March 31, 2021 44.18M
December 31, 2020 39.92M
September 30, 2020 39.92M
June 30, 2020 39.91M
Date Value
March 31, 2020 39.91M
December 31, 2019 39.90M
September 30, 2019 39.90M
June 30, 2019 39.90M
March 31, 2019 39.86M
December 31, 2018 39.86M
September 30, 2018 39.86M
June 30, 2018 39.83M
March 31, 2018 39.82M
December 31, 2017 38.48M
September 30, 2017 38.44M
June 30, 2017 38.16M
March 31, 2017 37.96M
December 31, 2016 34.75M
September 30, 2016 34.46M
June 30, 2016 34.38M
March 31, 2016 34.34M
December 31, 2015 31.74M
September 30, 2015 31.52M
June 30, 2015 31.38M
March 31, 2015 27.47M
December 31, 2014 27.39M
September 30, 2014 27.38M
June 30, 2014 26.66M
March 31, 2014 21.90M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Alkermes Plc 167.54M
Amarin Corp. Plc 21.00M
Agenus, Inc. 42.62M
Amgen, Inc. 540.60M
Anika Therapeutics, Inc. 13.38M